HRL Holdings Ltd operates in the Testing laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares HRL Holdings Ltd with three other
miscellaneous service companies in Australasia:
sales of 30.58 million Australian Dollars [US$20.99 million]
of which 98%
was Clinical Trials),
Clinuvel Pharmaceuticals Limited
(31.61 million Australian Dollars [US$21.70 million]
of which 100%
was Biotechnology), and
Site Group International Limited
(30.91 million Australian Dollars [US$21.22 million]
HRL Holdings Ltd reported sales of A$30.73 million (US$21.09 million)
June of 2019.
increase of 12.5%
versus 2018, when the company's sales were A$27.31 million.
Sales at HRL Holdings Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 147,224%).